Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 1999, p. 558-564, Vol. 37, No. 3
Viral and Rickettsial Zoonoses Branch,
National Center for Infectious Diseases, Centers for Disease
Control and Prevention, Public Health Service, U.S. Department of
Health and Human Services, Atlanta, Georgia
30333,1 and
Department of Molecular
Microbiology and Immunology, Johns Hopkins University School of
Hygiene and Public Health, Baltimore, Maryland
212052
Received 20 August 1998/Returned for modification 28 September
1998/Accepted 17 November 1998
An indirect immunofluorescence assay (IFA) was used to identify
patients with antibodies reactive to the human granulocytic ehrlichiosis (HGE) agent. Serum samples collected from clinically ill
individuals were submitted to the Centers for Disease Control and
Prevention by physicians via state health departments from throughout
the United States and tested against a panel of ehrlichial and
rickettsial pathogens. Antibodies reactive to the HGE agent were
detected in 142 (8.9%) of 1,602 individuals tested. There were 19 confirmed and 59 probable (n = 78) cases of HGE as
defined by seroconversion or a fourfold or higher titer to the HGE
agent than to the Ehrlichia chaffeensis antigens. The
average age of patients with HGE was 57 years, and males accounted for
53 (68%) of the patients. Cases of HGE occurred in 21 states; 47 (60%) of the cases occurred in Connecticut (n = 14),
New York (n = 18), and Wisconsin (n = 15). Onset of HGE was identified from April through December, with
cases peaking in June and July. The earliest confirmed cases of HGE
occurred in 1987 in Wisconsin and 1988 in Florida. No fatalities were
reported among the 78 patients with confirmed or probable HGE.
Reactivity to the HGE agent and to either Coxiella
burnetii, Rickettsia rickettsii, or Rickettsia typhi was infrequent; however, 74 (52%) of the 142 individuals who were positive for HGE had at least one serum sample that also reacted to the E. chaffeensis antigen. Thirty-four persons
with confirmed or probable human monocytic ehrlichiosis due to E. chaffeensis also had antibodies to the HGE agent in at least one
serum sample. The specific etiologic agent for 30 patients was not ascribed because of similarity of titers to both
ehrlichial antigens. The use of both antigens may be required to
correctly diagnose most cases of human ehrlichiosis, especially in
geographic regions where both the HGE agent and E. chaffeensis occur.
0095-1137/99/$00.00+0
Serologic Testing for Human Granulocytic
Ehrlichiosis at a National Referral Center
*
Corresponding author. Mailing address: Viral and
Rickettsial Zoonoses Branch, National Center for Infectious Diseases,
Centers for Disease Control and Prevention, 1600 Clifton Rd., Mailstop G-13, Atlanta, GA 30333. Phone: (404) 639-1075. Fax: (404) 639-4436. E-mail: jnc0{at}cdc.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»